PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Metabolism & Experimental Therapeutics, Division of Medicine, University College London, London, UK.\', \'Department of Endocrinology & Diabetes, Whittington Health NHS Trust, London, UK.\', \'National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.\', \'Department of Diabetes & Endocrinology, University College London Hospital NHS Foundation Trust, London, UK.\', \'Division of Medicine, University College London, London, UK.\', \'Centre for Neuroendocrinology, Royal Free Campus, University College London, London, UK.\', \'UCL Institute for Human Health and Performance, University College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1210/clinem/dgab107
?:doi
?:hasPublicationType
?:journal
  • The Journal of clinical endocrinology and metabolism
is ?:pmid of
?:pmid
?:pmid
  • 33624101
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all